Begin typing your search above and press return to search.
proflie-avatar
Login
exit_to_app
dollar
access_time 5 Dec 2024 12:22 PM GMT
Can Iran go nuclear?
access_time 5 Dec 2024 4:44 AM GMT
CPIM in cold sweat of implosion
access_time 4 Dec 2024 4:59 AM GMT
Farmers anger erupting again
access_time 3 Dec 2024 8:10 AM GMT
DEEP READ
Munambam Waqf issue decoded
access_time 16 Nov 2024 5:18 PM GMT
Ukraine
access_time 16 Aug 2023 5:46 AM GMT
Foreign espionage in the UK
access_time 22 Oct 2024 8:38 AM GMT
exit_to_app
Homechevron_rightWorldchevron_rightBrazil suspends import...

Brazil suspends import permit of Covaxin

text_fields
bookmark_border
Brazil suspends import permit of Covaxin
cancel

The National Health Surveillance Agency of Brazil, Anvisa, on Tuesday, suspended the temporary authorisation to import and distribute Covaxin. The country had earlier suspended the proposed clinical trials of Covaxin and the request for Emergency Use Authorisation. With the decision, the decision to import four million doses of Bharat Biotech manufactured Covaxin also stands suspended.

"The Collegiate Board of Anvisaunanimously decided, on Tuesday (27/7), to provisionally suspend the exceptional and temporary authorisation for import and distribution of the vaccine against Covid-19-Covaxin, requested by the Ministry of Health," Anvisa said.

The decision comes after Bharat Biotech informed the South American government on July 23 about the termination of its pact with its Brazilian partners Precisa Medicamentos and Envixia Pharmaceuticals LLC. The India-based vaccine manufacturer terminated the MoU with the companies after the deal with the Brazilian government to supply 20 million Covaxin doses landed in controversy and attracted investigation by the country authorities.

"The measure prevails until there is new information that allows us to conclude that the legal and technical security of maintaining the decision that authorised the importation is maintained," Anvisa added.

Brazil authorised the exceptional and temporary importation of Covaxin on June 4 at the ninth Extraordinary Meeting of the Collegiate Board of Anvisa. However, they never imported the vaccine.

Even while terminating the pact with its Brazilian partners, Bharat Biotech had informed that it would continue to work diligently with Anvisa to complete the regulatory approval process for Covaxin.

Show Full Article
TAGS:CovaxinBrazil
Next Story